NCT04252989

Atropine 0.01% Eyedrops for Evolutive Myopia Treatment in Children

Atropine 0.01% Eyedrops for Evolutive Myopia Treatment in Children. MYOPSTOP

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 50 (estimated)
• Sponsor: Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Prevalence of myopia and its complications has been increasing over the past decades, especially among children and adolescents. It reaches record levels in Asia: nearly 80% of the population in some regions in 2012 where the investigators speak in terms of epidemic. ATROPINE 0.01% eyedrops one drop per day is today an evolutive myopia treatment, whose results are promising. The investigators use this eye drops in our clinical practice at hospital of Saint-Etienne since 2017. Few clinical data have been published so far concerning the French population. The investigators would like to build a database so that the investigators can publish our results and share our experience.

Conditions

• Myopia
• Children

Interventions

Type	Name	Description
OTHER	data collection	* Demographic data: age, sex * Ophthalmological history: refraction of parents, previous refractions * Ophthalmological data at each examination: intra-ocular pression, objective refraction after "fog", cycloplegia with SKIACOL, slit lamp, dilated eye exam, biometrics * Potential undesirable events (halos, photophobia...)

Timeline

• Start date: 2019-12-18
• Primary completion: 2027-12-01
• Completion: 2027-12-01
• First posted: 2020-02-05
• Last updated: 2025-03-18

Locations

1 site across 1 country: France